William, I believe you're correct. The perception of a rate increase is much worse than the reality of it. .25 is not really that much. I'm hope the Fed makes the decision so we can back to "normal' whatever normal is. I recently bought NRZ and ARCC.
vin, be careful at The Villages, I read they have the highest number of reported cases of sexually transmitted decease in the U. S.
Sarge, I'm going to sit on the sideline for a while collect dividends, not buy anything. See how this plays out.
Been a long time since I made any buys, but last week I sold NYCB which I owned since 2010. Took the money and bought NRZ and ARCC.
Stagg, I read your recent post about "revenue stream." I assume you mean by revenue stream the dividends and distributions you receive from your stocks. I did not pay much attention to dividends until 2011, until then I had some stocks such as MO, T, and GE that paid between three and five percent. My dividend income was very meager at that time. I changed my investment model in 2011 to include stocks with dividends paying eight percent or higher. The first year my "revenue stream" increased by 68%--mainly because the dividend income was so low before that. Since then the numbers are 2012 - 2013 and increase of 27 percent, 2013 -2014 and increase of 44 percent and I project for 2014 - 2015 to be about 18 percent. I'm sure I'll not get this much growth in the future but hope to grow it around 10 percent a year.
I changed the way I looked at dividends l from listening to you and many of the investors on the SFL board to include such stocks NYMT, NYCB, SFL, PSEC, NMM, and WMC (which I no longer own.)
So far, this has been working well. I may not talk about it much, but I do pay attention to it.
from the "Street" Traders should now look for long-biased trades in Capital Product Partners as long as it's trending above its 20-day moving average of $6.75 and then once it sustains a move or close above Tuesday's high of $7.14 with volume that hits near or above 373,335 shares. If that move gets started soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $7.40 to $7.50, or even its 200-day moving average of $7.98 to $8.20 a share.
Mark, three stocks I bought years ago and put away and forgot about. They have all been very rewarding, but would not buy now except on a pull back. MO, T, CINF
"Bloody October": October 2015 was best one in four years. Now, if the rest of the year can find some steam with a "Thanksgiving" rally and a "Santa Clause" rally a "Pearl Harbor Day" rally and whatever other kind of rally we can have.
Stagg, you mentioned eye surgery, is it cataract surgery? If so, I had both eyes operated on a couple of years ago, everything went great. I can read everything but very small print without glasses. Good luck with whatever kind of surgery you are having.
Stagg, not sure what is going on at Zack's, but someone there says NMM will beat the .17 estimate my .05. Announcement is scheduled for Oct. 27.